Cerliponase alfa | Interleukin Related interleukin-related.com

Product Name :
Cerliponase alfa

Search keywords :
TPP1

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Tripeptidyl peptidase 1 replacements

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Biomarin Pharmaceutical Inc

Active Company_Name :
Biomarin International Ltd

Active Indication_Name:
Neuronal Ceroid-Lipofuscinoses

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FDFT1 Antibody
IL-1 alpha Antibody
Neomycin Antibody (YA907): Neomycin Antibody (YA907) is an unconjugated, rabbit-derived, anti-Neomycin (YA907) monoclonal antibody. Neomycin Antibody (YA907) can be used for: ELISA expriments in background without labeling.

Author: Interleukin Related

Related Posts